ClariVest Asset Management’s Filana Therapeutics FLNA Stock Holding History

ClariVest Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,203	Closed	-$324K	–	802
2021 Q3	$324K	Buy	+5,203	New	+$434K	0.01%	464
2020 Q2	–	Sell	-33,403	Closed	-$137K	–	840
2020 Q1	$137K	Buy	+33,403	New	+$221K	﹤0.01%	497
2014 Q4	–	Sell	-20,934	Closed	-$574K	–	605
2014 Q3	$574K	Buy	20,934 +77	+0.4%	+$2.34K	0.02%	263
2014 Q2	$840K	Buy	20,857 +19	+0.1%	+$703	0.03%	242
2014 Q1	$800K	Buy	20,838 +17,985	+630%	+$635K	0.03%	234
2013 Q4	$97K	Buy	+2,853	New	+$75.8K	﹤0.01%	429

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ClariVest Asset Management's FLNA Position: Q4 2021 in Review

ClariVest Asset Management sold out of Filana Therapeutics (FLNA) in Q4 2021, closing a stake of 5,203 shares — an estimated $324K sold.

ClariVest Asset Management first reported a position in FLNA in Q4 2013 and held it in 6 quarters. The position peaked at $840K in Q2 2014. 171 funds tracked by Wall St. Rank hold FLNA as of Q4 2021.

ClariVest Asset Management reported no remaining Filana Therapeutics position as of Q4 2021 after selling out during the quarter.
ClariVest Asset Management sold 5,203 Filana Therapeutics shares in Q4 2021, an estimated $324K.
ClariVest Asset Management first reported a position in Filana Therapeutics in Q4 2013 and held it in 6 quarters.
ClariVest Asset Management's Filana Therapeutics position peaked at $840K in Q2 2014.
171 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2021.

Based on ClariVest Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.